Literature DB >> 18193666

Lyme disease.

Eugene D Shapiro1.   

Abstract

We now have more than 30 years of solid, scientific research about Lyme disease, a relatively common, vector-borne illness in parts of the United States and of Europe. Although there is still widespread misunderstanding of and misinformation about the disease among the lay public, its clinical manifestations as well as how to diagnose and to treat it are now well understood. In the vast majority of cases simple treatment with a relatively short course of orally administered antimicrobials results in long-term cure with no adverse sequelae.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193666     DOI: 10.1007/978-0-387-73960-1_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Comparison of the Babesia duncani (WA1) IgG detection rates among clinical sera submitted to a reference laboratory for WA1 IgG testing and blood donor specimens from diverse geographic areas of the United States.

Authors:  Harry E Prince; Mary Lapé-Nixon; Hemlata Patel; Cindy Yeh
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

2.  CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi.

Authors:  Kelly L Hawley; Chris M Olson; Juan M Iglesias-Pedraz; Nicolás Navasa; Jorge L Cervantes; Melissa J Caimano; Hooman Izadi; Robin R Ingalls; Utpal Pal; Juan C Salazar; Justin D Radolf; Juan Anguita
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

3.  Seroprevalence of Lyme disease and associated risk factors in rural population of Beijing.

Authors:  Xiangfeng Dou; Yanning Lyu; Yi Jiang; Lili Tian; Xinyu Li; Changying Lin; Yulan Sun; Zengzhi Guan; Xiuchun Zhang; Quanyi Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.